An autoregulatory loop mediated by miR-21 and PDCD4 controls the AP-1 activity in RAS transformation

Oncogene

Volumn 28, Issue 1, 2009, Pages 73-84

  Talotta, F ^a   Cimmino, A ^b   Matarazzo, M R ^a   Casalino, L ^a   De Vita, G ^c   D'Esposito, M ^a   Di Lauro, R ^c   Verde, P ^a  

^a INSTITUTE OF GENETICS AND BIOPHYSICS ADRIANO BUZZATI TRAVERSO   (Italy)

^b SECOND UNIVERSITY OF NAPLES   (Italy)

^c UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

AP 1; miR 21; PDCD4; PTEN; RAS; Thyroid tumorigenesis

Indexed keywords

MICRORNA; MICRORNA 21; TRANSCRIPTION FACTOR AP 1; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOREGULATION; CARCINOGENESIS; CONTROL GROUP; CONTROLLED STUDY; DOWN REGULATION; NONHUMAN; PRIORITY JOURNAL; RAT; SOLID TUMOR; TUMOR SUPPRESSOR GENE;

ANIMALS; APOPTOSIS REGULATORY PROTEINS; CELL LINE, TUMOR; CELL SURVIVAL; CELL TRANSFORMATION, NEOPLASTIC; HOMEOSTASIS; HUMANS; MICRORNAS; PROTO-ONCOGENE PROTEINS C-FOS; PROTO-ONCOGENE PROTEINS C-JUN; PTEN PHOSPHOHYDROLASE; RAS PROTEINS; RATS; THYROID GLAND; TRANSCRIPTION FACTOR AP-1;

EID: 58149352800     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2008.370     Document Type: Article

References (53)

1. Ancrile B, Lim KH, Counter CM. (2007). Oncogenic Ras-induced secretion of IL6 is required for tumorigenesis. Genes Dev 21: 1714-1719.
2. Asangani IA, Rasheed SA, Nikolova DA, Leupold JH, Colburn NH, Post S et al. (2008). MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer. Oncogene 27: 2128-2136.
3. Bahassi el M, Karyala S, Tomlinson CR, Sartor MA, Medvedovic M, Hennigan RF. (2004). Critical regulation of genes for tumor cell migration by AP-1. Clin Exp Metastasis 21: 293-304.
4. Bakiri L, Lallemand D, Bossy-Wetzel E, Yaniv M. (2000). Cell cycle-dependent variations in c-Jun and JunB phosphorylation: a role in the control of cyclin D1 expression. EMBO J 19: 2056-2068.
5. Bakiri L, Matsuo K, Wisniewska M, Wagner EF, Yaniv M. (2002). Promoter specificity and biological activity of tethered AP-1 dimers. Mol Cell Biol 22: 4952-4964.
6. Bartel DP. (2004). MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116: 281-297.
7. Bitomsky N, Bohm M, Klempnauer KH. (2004). Transformation suppressor protein Pdcd4 interferes with JNK-mediated phosphorylation of c-Jun and recruitment of the coactivator p300 by c-Jun. Oncogene 23: 7484-7493.
8. Cai X, Hagedorn CH, Cullen BR. (2004). Human microRNAs are processed from capped, polyadenylated transcripts that can also function as mRNAs. RNA 10: 1957-1966.
9. Calin GA, Croce CM. (2006). MicroRNA signatures in human cancers. Nat Rev Cancer 6: 857-866.
10. Casalino L, De Cesare D, Verde P. (2003). Accumulation of Fra-1 in ras-transformed cells depends on both transcriptional autoregulation and MEK-dependent posttranslational stabilization. Mol Cell Biol 23: 4401-4415.
11. Chan JA, Krichevsky AM, Kosik KS. (2005). MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells. Cancer Res 65: 6029-6033.
12. Cimmino A, Calin GA, Fabbri M, Iorio MV, Ferracin M, Shimizu M et al. (2005). miR-15 and miR-16 induce apoptosis by targeting BCL2. Proc Natl Acad Sci USA 102: 13944-13949.
13. Corsten MF, Miranda R, Kasmieh R, Krichevsky AM, Weissleder R, Shah K. (2007). MicroRNA-21 knockdown disrupts glioma growth in vivo and displays synergistic cytotoxicity with neural precursor cell delivered S-TRAIL in human gliomas. Cancer Res 67: 8994-9000.
14. Davis BN, Hilyard AC, Lagna G, Hata A. (2008). SMAD proteins control DROSHA-mediated microRNA maturation. Nature 454: 56-61.
15. De Vita G, Bauer L, da Costa VM, De Felice M, Baratta MG, De Menna M et al. (2005). Dose-dependent inhibition of thyroid differentiation by RAS oncogenes. Mol Endocrinol 19: 76-89.
16. Dorrello NV, Peschiaroli A, Guardavaccaro D, Colburn NH, Sherman NE, Pagano M. (2006). S6K1- and betaTRCP-mediated degradation of PDCD4 promotes protein translation and cell growth. Science 314: 467-471.
17. Eferl R, Wagner EF. (2003). AP-1: a double-edged sword in tumorigenesis. Nat Rev Cancer 3: 859-868.
18. Elmen J, Lindow M, Schutz S, Lawrence M, Petri A, Obad S et al. (2008). LNA-mediated microRNA silencing in non-human primates. Nature 452: 896-899.
19. Esquela-Kerscher A, Slack FJ. (2006). Oncomirs - microRNAs with a role in cancer. Nat Rev Cancer 6: 259-269.
20. Frankel LB, Christoffersen NR, Jacobsen A, Lindow M, Krogh A, Lund AH. (2008). Programmed cell death 4 (PDCD4) is an important functional target of the microRNA miR-21 in breast cancer cells. J Biol Chem 283: 1026-1033.
21. Fujita S, Iba H. (2008). Putative promoter regions of miRNA genes involved in evolutionarily conserved regulatory systems among vertebrates. Bioinformatics 24: 303-308.
22. Fujita S, Ito T, Mizutani T, Minoguchi S, Yamamichi N, Sakurai K et al. (2008). miR-21 Gene expression triggered by AP-1 is sustained through a double-negative feedback mechanism. J Mol Biol 378: 492-504.
23. Fulci V, Chiaretti S, Goldoni M, Azzalin G, Carucci N, Tavolaro S et al. (2007). Quantitative technologies establish a novel microRNA profile of chronic lymphocytic leukemia. Blood 109: 4944-4951.
24. He H, Jazdzewski K, Li W, Liyanarachchi S, Nagy R, Volinia S et al. (2005). The role of microRNA genes in papillary thyroid carcinoma. Proc Natl Acad Sci USA 102: 19075-19080.
25. He X, He L, Hannon GJ. (2007). The guardian's little helper: microRNAs in the p53 tumor suppressor network. Cancer Res 67: 11099-11101.
26. Hettinger K, Vikhanskaya F, Poh MK, Lee MK, de Belle I, Zhang JT et al. (2007). c-Jun promotes cellular survival by suppression of PTEN. Cell Death Differ 14: 218-229.
27. Iorio MV, Ferracin M, Liu CG, Veronese A, Spizzo R, Sabbioni S et al. (2005). MicroRNA gene expression deregulation in human breast cancer. Cancer Res 65: 7065-7070..
28. Jansen AP, Camalier CE, Colburn NH. (2005). Epidermal expression of the translation inhibitor programmed cell death 4 suppresses tumorigenesis. Cancer Res 65: 6034-6041.
29. Landgraf P, Rusu M, Sheridan R, Sewer A, Iovino N, Aravin A et al. (2007). A mammalian microRNA expression atlas based on small RNA library sequencing. Cell 129: 1401-1414.
30. Leupold JH, Yang HS, Colburn NH, Asangani I, Post S, Allgayer H. (2007). Tumor suppressor Pdcd4 inhibits invasion/intravasation and regulates urokinase receptor (u-PAR) gene expression via Sp-transcription factors. Oncogene 26: 4550-4562.
31. Lim LP, Lau NC, Garrett-Engele P, Grimson A, Schelter JM, Castle J et al. (2005). Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs. Nature 433: 769-773.
32. Loffler D, Brocke-Heidrich K, Pfeifer G, Stocsits C, Hackermuller J, Kretzschmar AK et al. (2007). Interleukin-6 dependent survival of multiple myeloma cells involves the Stat3-mediated induction of microRNA-21 through a highly conserved enhancer. Blood 110: 1330-1333.
33. Lu Z, Liu M, Stribinskis V, Klinge CM, Ramos KS, Colburn NH et al. (2008). MicroRNA-21 promotes cell transformation by targeting the programmed cell death 4 gene. Oncogene 27: 4373-4379.
34. Mechta F, Lallemand D, Pfarr CM, Yaniv M. (1997). Transformation by ras modifies AP1 composition and activity. Oncogene 14: 837-847.
35. Meng F, Henson R, Lang M, Wehbe H, Maheshwari S, Mendell JT et al. (2006). Involvement of human micro-RNA in growth and response to chemotherapy in human cholangiocarcinoma cell lines. Gastroenterology 130: 2113-2129.
36. Meng F, Henson R, Wehbe-Janek H, Ghoshal K, Jacob ST, Patel T. (2007). MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer. Gastroenterology 133: 647-658.
37. O'Donnell KA, Wentzel EA, Zeller KI, Dang CV, Mendell JT. (2005). c-Myc-regulated microRNAs modulate E2F1 expression. Nature 435: 839-843.
38. Olive M, Krylov D, Echlin DR, Gardner K, Taparowsky E, Vinson C. (1997). A dominant negative to activation protein-1 (AP1) that abolishes DNA binding and inhibits oncogenesis. J Biol Chem 272: 18586-18594.
39. Ozanne BW, Spence HJ, McGarry LC, Hennigan RF. (2007). Transcription factors control invasion: AP-1 the first among equals. Oncogene 26: 1-10.
40. Pallante P, Visone R, Ferracin M, Ferraro A, Berlingieri MT, Troncone G et al. (2006). MicroRNA deregulation in human thyroid papillary carcinomas. Endocr Relat Cancer 13: 497-508.
41. Shaulian E, Karin M. (2002). AP-1 as a regulator of cell life and death. Nat Cell Biol 4: E131-E136.
42. Si ML, Zhu S, Wu H, Lu Z, Wu F, Mo YY. (2007). miR-21-mediated tumor growth. Oncogene 26: 2799-2803.
43. Vallone D, Battista S, Pierantoni GM, Fedele M, Casalino L, Santoro M et al. (1997). Neoplastic transformation of rat thyroid cells requires the junB and fra-1 gene induction, which is dependent on the HMGI-C gene product. EMBO J 16: 5310-5321.
44. Vasudevan KM, Burikhanov R, Goswami A, Rangnekar VM. (2007). Suppression of PTEN expression is essential for antiapoptosis and cellular transformation by oncogenic Ras. Cancer Res 67: 10343-10350.
45. Volinia S, Calin GA, Liu CG, Ambs S, Cimmino A, Petrocca F et al. (2006). A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci USA 103: 2257-2261.
46. Wang Q, Sun Z, Yang HS. (2007). Downregulation of tumor suppressor Pdcd4 promotes invasion and activates both beta-catenin/Tcf and AP-1-dependent transcription in colon carcinoma cells. Oncogene 27: 1527-1535.
47. Yang HS, Jansen AP, Komar AA, Zheng X, Merrick WC, Costes S et al. (2003a). The transformation suppressor Pdcd4 is a novel eukaryotic translation initiation factor 4A binding protein that inhibits translation. Mol Cell Biol 23: 26-37.
48. Yang HS, Knies JL, Stark C, Colburn NH. (2003b). Pdcd4 suppresses tumor phenotype in JB6 cells by inhibiting AP-1 transactivation. Oncogene 22: 3712-3720.
49. Yang HS, Matthews CP, Clair T, Wang Q, Baker AR, Li CC et al. (2006). Tumorigenesis suppressor Pdcd4 down-regulates mitogen-activated protein kinase kinase kinase kinase 1 expression to suppress colon carcinoma cell invasion. Mol Cell Biol 26: 1297-1306.
50. Young MR, Li JJ, Rincon M, Flavell RA, Sathyanarayana BK, Hunziker R et al. (1999). Transgenic mice demonstrate AP-1 (activator protein-1) transactivation is required for tumor promotion. Proc Natl Acad Sci USA 96: 9827-9832.
51. Yu SL, Chen HY, Chang GC, Chen CY, Chen HW, Singh S et al. (2008). MicroRNA signature predicts survival and relapse in lung cancer. Cancer Cell 13: 48-57.
52. Zhu S, Si ML, Wu H, Mo YY. (2007). MicroRNA-21 targets the tumor suppressor gene tropomyosin 1 (TPM1). J Biol Chem 282: 14328-14336.
53. Zhu S, Wu H, Wu F, Nie D, Sheng S, Mo YY. (2008). MicroRNA-21 targets tumor suppressor genes in invasion and metastasis. Cell Res 18: 350-359.